Insmed (INSM) Change in Accured Expenses (2010 - 2026)

Insmed has reported Change in Accured Expenses for 17 years, with the latest figure at $68.8 million in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 168.22% year-over-year to $68.8 million in Q2 2026; TTM through Jun 2026 was $170.8 million, a 1001.69% increase from a year earlier, with the FY2025 full-year figure at $100.1 million, up 124.42% from the prior year.
• Change in Accured Expenses was $68.8 million for Q2 2026 at Insmed, up from -$33.9 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $90.3 million in Q4 2025, with the low at -$61.5 million in Q1 2025.
• Average Change in Accured Expenses over 5 years is $10.1 million, with a median of $5.1 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses sank 265.85% in 2024, then jumped 7448.23% in 2025.
• Over 5 years, Change in Accured Expenses stood at $8.8 million in 2022, then soared by 147.59% to $21.7 million in 2023, then surged by 139.35% to $52.0 million in 2024, then surged by 73.88% to $90.3 million in 2025, then fell by 23.83% to $68.8 million in 2026.
• The last three Change in Accured Expenses figures came in at $68.8 million (Q2 2026), -$33.9 million (Q1 2026), and $90.3 million (Q4 2025), per Business Quant data.